Funding Opportunities AACR and Pelotonia announce scientific achievement awards for women’s cancers, funded by The Victoria’s Secret Global Fund for Women’s Cancers December 03, 2021Vol.47 No.44
Clinical Roundup Yale Cancer Center researchers link ALK receptor structure to targets for cancer treatment December 03, 2021Vol.47 No.44
Clinical Roundup IMGN853 linked to improved outcomes in (FRα)-high platinum-resistant ovarian cancer December 03, 2021Vol.47 No.44
Clinical Roundup Fox Chase’s Suzanne Miller develops special edition of Translational Behavioral Medicine December 03, 2021Vol.47 No.44
Drugs & Targets FDA approves Fyarro for malignant perivascular epithelioid cell tumor December 03, 2021Vol.47 No.44
Drugs & Targets FDA approves Darzalex Faspro, Kyprolis, and Dexamethasone for multiple myeloma December 03, 2021Vol.47 No.44
Drugs & Targets FDA approves Cytalux for identifying malignant ovarian cancer lesions December 03, 2021Vol.47 No.44
Drugs & Targets FDA grants orphan drug designation to UV1 cancer vaccine in metastatic melanoma December 03, 2021Vol.47 No.44
Drugs & Targets European Commission approves Keytruda plus Lenvima for patients with certain types of endometrial carcinoma December 03, 2021Vol.47 No.44
